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Abstract 
Background People who suffer from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 
(ME/CFS) often report that their eye movements are sluggish and that they have difficulties 
tracking moving objects. However, descriptions of these visual problems are based solely on 
patients’ self-reports of their subjective visual experiences and there is a distinct lack of 
empirical evidence to objectively verify their claims. This paper presents the first 
experimental research to objectively examine eye movements in those suffering from 
ME/CFS. 
Methods Patients were assessed for ME/CFS symptoms and were compared to age, gender 
and education matched controls for their ability to generate saccades and smooth pursuit eye 
movements.  
Results Patients and controls exhibited similar error rates and saccade latencies (response 
times) on prosaccade and antisaccade tasks. Patients showed relatively intact ability to 
accurately fixate the target (prosaccades) but were impaired when required to focus 
accurately in a specific position opposite the target (antisaccades). Patients were most 
markedly impaired when required to direct their gaze as closely as possible to a smoothly 
moving target (smooth pursuit). 
Conclusions It is hypothesised that the effects of ME/CFS can be overcome briefly for 
completion of saccades, but that continuous pursuit activity (accurately tracking a moving 
object) even for a short time period highlights dysfunctional eye movement behaviour in 
ME/CFS patients. Future smooth pursuit research may elucidate and improve diagnosis of 
ME/CFS. 
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1. Introduction 
 
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is an acquired illness, its 
most salient symptoms being an increased susceptibility to fatigue, with fatigue levels often 
becoming severely debilitating. ME/CFS affects many individuals and its prevalence has 
been estimated to be between 0.2 and 0.4% of the population [1]. The illness also has 
widespread physiological impact and has been shown to affect the immune system [2] , the 
central nervous system [3] , and the cardiovascular system [4].
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There are a variety of case definitions for ME/CFS [7] and the most widely used for research 
is the 1994 Center for Disease Control and Prevention (CDC) definition [8]. Other case 
definitions for ME/CFS have been developed [5, 6], though to date none of these definitions 
have been formally operationalised. Diagnosing ME/CFS is based on categorising the range 
of symptoms reported by patients and differentiating them from the symptoms occurring with 
other fatigue related illnesses. It is a diagnosis of exclusion because there is currently no 
specific diagnostic test for ME/CFS [7]. This diagnosis can be problematic due to the number 
of symptoms overlapping with other illnesses and the reliance on patients to report their 
symptoms accurately. As such, research has begun to focus more on trying to objectively 
quantify the symptoms that sufferers of ME/CFS commonly report with a view to delineating 
the condition from other illnesses, such as depression, where there may be some symptom 
overlap and with which patients are commonly misdiagnosed [9]. 
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 For comprehensive reviews of ME/CFS, see [5,6]. 
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Patients who suffer from ME/CFS often report that they require increased mental effort, 
relative to that required before the onset of their illness, to complete everyday activities that 
require cognition. Experimentally, ME/CFS patients perform poorly, relative to controls, at 
tasks assessing attentional and working memory capacity [10-13]. Furthermore, a number of 
recent neuroimaging studies have shown increased brain activation in ME/CFS patients 
relative to control participants during cognitive tasks [14-16]. Moreover, studies that have 
produced experimental evidence of cognitive problems associated with ME/CFS have 
demonstrated that objective measures correlate well with patients’ subjective symptom 
reports [10, 16]. 
 
Fatigue-related symptoms reported by those who suffer from ME/CFS are by no means 
restricted to the cognitive domain. Questionnaire-based studies have revealed that patients 
consistently report that they experience a range of visual and vision-related problems 
associated with their condition. These typically include pain in the eyes, increased sensitivity 
to light, ghosting and double vision, difficulty in directing attention, difficulty focusing on 
images, slow eye movements, difficulty tracking object movement and headaches during 
reading [17-19]. Moreover, ME/CFS sufferers also report that the visual problems they 
experience often become a pervasive part of their condition, exacerbate other symptoms and 
affect their ability to carry out everyday tasks such as reading or driving [17-19]. Indeed, 
some studies report that up to 25% of those suffering from CFS reduce the frequency of 
driving or stop driving completely due to the visual problems they experience
 
[18]. 
 
One of the primary visual disturbances reported by those who suffer from ME/CFS is that 
they experience difficulty and increased fatigue in everyday tasks that involve moving their 
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eyes. In this context, they often report particular difficultly when reading, a task that involves 
fine eye-movements for a prolonged period of time. These and other visual symptoms could 
be explained by poor muscular control relating to the focus (accommodation via the ciliary 
muscle), light and dark sensitivity (iris contraction via the iris sphincter muscle) and 
movement (eye movement by the extraocular muscles) of the eye. This would correspond to 
motor disturbances in ME/CFS reported by [5] and ME/CFS related central nervous system 
dysfunction cf. [3]. Establishing the characteristics of eye movement problems in ME/CFS is 
therefore important because doing so may: (1) provide further understanding of the symptoms 
related to ME/CFS; (2) provide insights into pathophysiological impacts of the condition and 
(3) provide an objective measure that could be used in its diagnosis and, in particular, provide 
a means by which it may be distinguished from other conditions.  
 
Despite consistent reports by ME/CFS patients of difficulty performing tasks requiring eye 
movements, there has been no attempt to experimentally establish the characteristics of their 
eye movements.  The purpose of the current study was to assess the nature and extent of eye 
movement anomalies in ME/CFS. This is the first experimental attempt to do so. As such, we 
have followed the experimental parameters used previously in the schizophrenia literature 
[20], where eye movement analysis is common.  
 
2. Material and methods 
 
2.1. Participants 
Twenty patients and twenty age, gender and education matched control participants 
participated in the study. Patients were recruited by local advertising. They were refunded 
travel expenses for volunteering and were offered rest breaks on a regular basis throughout 
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the session. Control participants were recruited from the local community and were 
compensated £10 for their time. All of the patients reported that they had been given a 
diagnosis of ME/CFS by a medical practitioner. Before being admitted to the study, they 
completed the DePaul Symptom Questionnaire [21] which is a useful screening tool recently 
developed to assess for ME/CFS. Using this tool, it could be ascertained whether patients 
fulfilled the standard CDC Definition [8], the Canadian ME/CFS Case Definition [5], or the 
International Consensus ME Case Definition [6]. Table 1 contains a summary of patients’ and 
control participants’ details. Participants had no history of eye disease. Before the main 
experiment commenced, visual acuity was assessed using the Freiburg Acuity Test [22]. 
Normal or corrected-to-normal acuity (decimal) was within the normal range and there were 
no differences between patients and controls [M = 1.27, SD = 0.29; M = 1.31, SD = 0.20, 
respectively, t < 1]. Ethical approval was granted by School of Psychology Ethics Committee 
at the University of Leicester and the National Research Ethics Service. All experimental 
methods adhered to the tenets of the Declaration of Helsinki. 
 
2.2. Apparatus, stimuli and procedure 
 
2.2.1. Cognitive Speed 
All participants completed the Digit Symbol Substitution Task (DSST, [23]). The DSST is a 
robust measure of cognitive speed. It has been shown to relate to depression [24], and is also 
commonly used in cognitive aging literature to assess cognitive speed and working memory 
[25]. A set of digits were presented on a sheet of paper with a key that associated each digit to 
an abstract symbol. A grid of digits was presented on the same sheet and participants were 
required to fill in below each digit the corresponding symbol from the key as fast as possible 
for 90 s. 
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2.2.2. Eye movement recording 
 
Stimuli were generated using a windows PC and presented on a 100Hz CRT monitor. At the 
viewing distance of 70 cm, 1 screen pixel subtended 0.0315 degrees of visual angle. 
Participants’ heads were supported and their eye movements were recorded using the Eyelink 
1000 eye tracking system (SR Research, Ontario, Canada). The gaze position of the right eye  
was sampled at 1000Hz and the Eyelink 1000 system has < 0.01º of gaze resolution (noise 
limited) and gaze position accuracy of < 0.5º. Testing took place in a dimly lit room where 
the monitor was the main light source. The background luminance of the monitor was 
approximately 51 cd/m
2
 . Measurements were taken using an LS-100 spot photometer 
(Konica Minolta). 
A nine-point calibration was conducted before each test measurement and calibration was 
repeated until it was labelled as accurate by the manufacturer's software. Calibration 
involved fixating on a target randomly appearing in each of nine different locations spread 
evenly across the display. Binocular status was not measured and any differences in binocular 
status between groups were not therefore controlled. 
 
2.2.2.1 Prosaccades and Antisaccades 
For the prosaccade and antisaccade tasks, a central, circular fixation point was presented in 
black (0.47˚ diameter) for a minimum of 800 ms. If the participant’s eye was focused within 
2.3˚ of the fixation point then the target was allowed to appear. The target was a red circle 
(0.63˚ diameter) which appeared randomly 12˚ to the left or right of the fixation point. The 
target would disappear after 1200 ms had passed. This was followed by a blank screen for 
500 ms before the next trial commenced. Before each task, the eye tracker was calibrated and 
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participants completed 20 practice trials. The eye tracker was then recalibrated and 
participants completed 40 experimental trials. For the prosaccade task, participants were 
instructed to look at the central fixation point and to then look at the centre of the red target 
when it appeared. For the antisaccade task, participants were instructed to look at the central 
fixation point and to then look away from the target, in the opposite direction, the same 
distance as the target appears from the fixation. 
 
2.2.2.2. Smooth Pursuit 
Sinusoidal pursuit stimuli replicated those previously employed by Holzman and colleagues 
[20, 26]. The amplitude, frequency and number of sinusoidal target oscillations were the 
modal parameters of 22 studies reported in a recent review [27]. Participants were instructed 
to follow with their eyes the centre of a red circular target of diameter 0.63˚ as it completed 
12 sinusoidal oscillations (lasting 30s in total) horizontally across the screen. The amplitude 
of the oscillations was 10˚ and the frequency was 0.4 Hz. The target commenced from a fixed 
starting point 5˚ left of the centre of the screen. The target would not begin movement until 
participants were fixating within 2.3˚ of its centre. Each participant performed the smooth 
pursuit task three times. The eye tracker was calibrated anew before each of the three trials. 
 
2.3. Counterbalancing 
Participants always completed the DSST task first. The saccade tasks were always performed 
together with the prosaccade task before the antisaccade task. The smooth pursuit tasks were 
also always performed together. Counterbalancing randomly placed the saccade tasks before 
the smooth pursuit tasks or vice versa. Each individual patient was matched to a specific 
control participant with both individuals completing their tests in the same order. 
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2.4. Data analysis 
 
2.4.1. Cognitive Speed (Digit Symbol Substitution Task) 
Cognitive speed was determined by the number of symbols correctly substituted within 90 s. 
 
2.4.2. Prosaccades and Antisaccades 
Correct saccades were those leading to fixations in the direction of the target (for 
prosaccades) or in the opposite direction to the target (for antisaccades). Trials were excluded 
if participants did not respond within the 1200 ms target presentation period (less than 1% of 
the data). Saccade latency was measured for correct trials as the time from target onset to the 
time of first fixation after target onset. Positional error was calculated as the distance (number 
of screen pixels) between the eye gaze to the target (prosaccades) or the distance between the 
eye gaze to the mirror position opposite the target (antisaccades). These values were 
converted from pixels to degrees. 
 
2.4.2. Smooth Pursuit 
Maintenance gain and root mean square (RMS) distance between the gaze and target position 
were calculated after excluding data similarly to O’Driscol and colleagues [28]. A 650 ms 
region centred at the peak target velocity was used in the calculations. Areas of the trace 
excluded were the first half cycle, 200 milliseconds before and after each blink, and saccades. 
Saccades were defined as eye movements with acceleration greater than 3500˚/s2 or eye 
movements with speed more than 22˚/s faster than the on-going pursuit speed. These 
exclusions were also verified by visual inspection. Gain was calculated as the eye velocity 
divided by the target velocity and outlying values (greater than two or below zero) were 
excluded before calculating mean and median gain. It should be noted that the influence of 
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peripheral saccade effects on gain measurements is difficult to determine from the current 
data. The RMS distance of the pursuit was calculated (after excluding blinks and saccades) 
by summing squares of the mean distance (deg) between the gaze and target position and 
square rooting that value. Catch up saccades (CUS) and anticipatory saccades (AS) were also 
calculated in accordance with the definitions described by Ross and colleagues [29]. CUS 
were calculated as saccades that started behind the target that reduced positional error by at 
least 50%. AS were calculated as saccades that either started or finished ahead of the target, 
or saccades that started behind the target, were at least 1˚, and increased positional error by at 
least 50%.  
 
3. Results 
 
3.1. Digit Symbol Substitution Task 
 In line with the aging literature, performance correlated negatively with age [r(20) = -.46, p 
< .01], indicating that the test was conducted successfully. Importantly, there were no 
differences in number of symbols copied between patients and controls [M = 55.4, SD = 
13.26; M = 60.75, SD = 10.08, respectively; t(38) = 1.44, ns]. 
 
3.2. Prosaccades and antisaccades 
 
Figure 1 shows average (a) error-rate (failure to produce a saccade in the correct direction), 
(b) saccade latency (msecs) and (c) positional error (distance (deg) between eye gaze position 
and the desired fixation point) for ME/CFS patients and control participants when carrying 
out the prosaccade and antisaccade tasks. Patient and control error-rates did not differ for 
prosaccadic [t(38) = 1.50, ns] or antisaccadic [t(38) = 1.04, ns] eye movements (Fig 1a). 
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However, saccade latency was larger (slower reactions) in patients compared to controls (Fig 
1b).  This effect reached marginal significance for prosaccades [t(25.46
2
) = 1.77, p = .09] but 
not for antisaccades [t < 1]. Patients also exhibited larger positional errors than controls. This 
effect reached marginal significance for prosaccades [t(29.87) = 1.94, p = .06] and was 
striking for antisaccades [t(25.87) = 3.02,  p <.01], indicating that ME/CFS patients 
particularly struggled when required to direct their gaze at a specific point opposite the target 
when there was no object to fixate upon. Also, although there was no effect of age on the 
extent of positional errors for control participants, patients’ antisaccade positional errors 
correlated positively with age [r(20) = .53, p <.05], suggesting that the visual effects of 
ME/CFS have a greater impact with increasing age. 
 
3.3. Smooth pursuit 
 
Figure 2 shows (a) mean maintenance gain between the eye position (gaze) and the target 
position (eye velocity divided by the target velocity), (b) global root mean square (RMS) 
error, (c) catch up saccade frequency (Hz) and (d) anticipatory saccade frequency (Hz) for 
ME/CFS patients and control participants when carrying out the smooth pursuit task across 
three test runs. Performance was assessed by conducting 2 (Group: patients, controls) x 3 
(Test Run: 1
st
, 2
nd
, 3
rd
) mixed ANOVAS on each experimental measure of smooth pursuit 
quality. Where there was evidence of departure from the sphericity assumption, Greenhouse–
Geisser corrections to degrees of freedom and p-values are reported. 
  
                                                          
2
 Degrees of freedom adjusted because Levene’s test for equality of variances was significant. 
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For mean maintenance gain (Fig 2a), there was a marginal effect of group [F(1, 38) = 2.98, 
MSE = 0.26, p = .09], with patients performing worse (exhibited lower gain) than controls. 
There was a also main effect of test run [F(2, 76) = 3.61, MSE = 0.01, p < .05] with 
performance being highest in the first, the second and then the third test runs. Although, at 
least numerically, performance declined more for patients than controls across the three test 
runs
3
, there was no interaction between factors.  
 
A clearer pattern was found with log10 global RMS error (Fig 2b). There was a main effect of 
group [F(1, 38) = 4.75, MSE = 2.17, p <.05] with patients performing significantly worse 
than controls, and a main effect of test run [F(2, 76) = 6.49, MSE = 0.08, p < .01] with 
performance being best in the first test run and deteriorating in the second and third test runs. 
There was also a marginal group by test run interaction [F(2, 76) = 2.32, MSE = 0.03, p =.11] 
with patients showing a larger drop in performance from the first test run to the second and 
third test runs than controls. Follow up Bonferroni adjusted (for six comparisons) paired t-
tests confirmed this pattern of results. Patients performed significantly better in the first test 
run compared to the second test run [t(19) = 3.97, p < .01] and in the first test run compared 
to the third test run [t(19) = 3.31, p < .05]. For the second test run compared to the third test 
run there was no difference for patients. None of the comparisons showed any differences for 
controls [all ts < /= 1]. This demonstrated that for the patients only, performance deteriorated 
as the testing session went on.  
 
For catch up saccade (CUS) frequency (Fig 2c), although there was no main effect of group 
[F < 1], there was a main effect of test run [F(1.47, 55.92) = 5.70, MSE = 0.29, p <.05], with 
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 A similar pattern of results was found with the median gains averaged for each participant. 
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poorer performance (more catch up saccades) in the first test run compared to the second and 
third test runs. There was no interaction between the factors. 
 
Finally, for anticipatory saccade (AS) frequency (Fig 2d), there was no main effect of group 
[F(1, 38) = 1.36, MSE = 3.67, ns], although there was a main effect of test run [F(2, 76) = 
6.62, MSE = 0.68, p <.01], with more AS in the second test run compared to the first and 
third test runs. A significant interaction between the factors [F(2, 76) = 4.55, MSE = 0.47, p < 
.05] indicated that this was driven by the patients. This was confirmed by follow up 
Bonferroni adjusted (for six comparisons) paired t-tests. For patients, there were significantly 
more AS in the second test run compared to the first test run [t(19) = 3.95, p <.01] and 
compared to the third test run [t(19) = 3.81, p < .01]. There were no other differences in AS 
between test runs for patients or controls [all ts < 1.72]. The AS data also showed a 
significant correlation with age for the patient group for the first [r(20) = 0.68; p < .01], 
second [r(20) = 0.53; p < .05], and third [r(20) = 0.58; p < .01] test runs (poorer performance 
with increasing age). This was not the case for control participants on any of the test runs and 
therefore indicates a greater impact of ME/CFS with increasing age. 
 
4. Discussion 
 
This study is the first to objectively assess eye-movement problems in those suffering form 
ME/CFS. In accordance with subjective reports, we found that patients generally performed 
worse than controls in tasks that required quick and accurate eye movements. Patients were 
only slightly impaired on tasks that required prosaccadic eye movements (those towards the 
target). The effects of ME/CFS on the ability to perform antisaccades (eye movements 
towards the hemispace opposite the target) were more pronounced, particularly for positional 
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errors. The smooth pursuit task highlighted clear differences between patients and controls. 
Firstly, patients showed general deficits in their ability to closely track the moving target. 
Secondly, across the three test sessions, patients’ performance deteriorated more than control 
participants’ performance. 
 
In the context of saccadic eye movements, patients and controls exhibited similar error rates 
and saccade latencies (response times). Patients also showed a relatively intact ability to 
accurately fixate on objects appearing within their field of view (prosaccades). The most 
notable area of difficulty for patients was a reduced ability to focus accurately in a specific 
position opposite the target (antisaccades). The key difference between the prosaccade task 
and the antisaccade task in this respect is that the former requires individuals to fixate on a 
clearly presented target, whilst the latter requires individuals to judge the fixation point 
themselves. As such, these findings may reflect poorer spatial awareness in patients than in 
controls and/or an inability to swiftly recall the exact position on which to focus when 
directing their gaze away from the target. Indeed, ME/CFS-related deficits in attention-based 
tasks have been shown previously [12]. Importantly, the presence of intact and dysfunctional 
performance within a single (antisaccade) task indicates a potential area in which to learn 
more about the selective visual/cognitive impairments related to ME/CFS. 
 
Mean maintenance gain and log10 global RMS error measures of smooth pursuit quality 
yielded poorer performance in patients relative to controls. These smooth pursuit deficits 
exhibited by ME/CFS patients may represent an important diagnostic measure that could be 
used in future objective assessment of ME/CFS. Patients were not only poorer at the task 
relative to controls but this deficit increased throughout the test session. This indicates that 
the task was able to measure patients’ increased susceptibility to the effects of fatigue on a 
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short time scale (the three smooth pursuit test runs took place across approximately 5-10 
minutes including time to calibrate the equipment). The smooth pursuit task required 
sustained musculature activity for 30 s and this may be a factor that differentiates it from the 
saccade tasks where a brief eye movement is followed by 1-2 s of inactivity. Carruthers and 
colleagues [5] highlight the commonality of motor disturbances and Michiels and colleagues 
[12] identified dysfunctional control of attention in ME/CFS patients. It may be the case that 
patients are able to overcome their dysfunction for brief saccade tasks but not for continuous 
pursuit. In this respect, future research should aim to establish which factors mediate patient 
deficits in smooth pursuit. If a task with large and consistent deficits can be found, then 
diagnosis of ME/CFS may be improved by the inclusion tasks of this type.  
 
One, somewhat unexpected, finding was that the severity of some of deficits revealed by the 
eye movement measures were correlated with age for patients but not controls. The frequency 
of anticipatory saccades produced by patients correlated positively with age for all three test 
runs whilst there were no correlations for control participants. The same was found for the 
antisaccade positional errors, which were significantly greater with increasing age for patients 
but not for control participants. This suggests that the visual effects of ME/CFS are greater 
for older adults and indicates that the illness may be more debilitating for them, presumably 
because they are less able than young adults to compensate for ME/CFS related deficits. 
Similar results are apparent in depression where there is evidence that symptoms are more 
chronic in older adults compared to young adults [30]. 
 
Under the current testing conditions, we cannot rule out the possibility that blur may have 
contributed to our findings.  The first consideration concerns older participants. We used the 
Freiburg Acuity Test to assess normal/corrected-to-normal visual acuity for long distance 
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vision. However, at the viewing distance of 70 cm employed in this study, older participants 
may have been more prone to the effects of blur due to presbyopia. Given that patients and 
control participants were matched on the basis of age, it is unlikely that this would be a 
driving factor. The second consideration concerns ME/CFS. In this context, blur may indeed 
offer an explanation for our findings. Individuals with ME/CFS often report that they 
experience a number of symptoms related to blurred vision [18] to the extent that being 
‘unable to focus vision’ has been incorporated into some diagnostic measures of the condition 
[21]. As a consequence, the red circle may have appeared more ‘blurry’ to patients than to 
controls, deleteriously affecting their ability to accurately track it as it moved across the 
screen. The issue of blur in ME/CFS is interesting in that it may represent an underlying 
factor in a number of the visual anomalies reported by those with ME/CFS and, as such, 
warrants further study. 
 
In conclusion, this study was able to experimentally determine visual dysfunction in ME/CFS 
patients. Our findings are in good agreement with previous questionnaire based studies [17-
19]. It is particularly noteworthy that ME/CFS patients performed well on many aspects of 
the antisaccade tasks (error rate and saccade latency), yet they showed dysfunctional smooth 
pursuit ability. This differentiates the current pattern of results from those exhibited by 
patients with disorders such as schizophrenia, where patients show dysfunction on both tasks 
[20]. This pattern of results also supports reports by patients that they experience particular 
difficulty when they are required to track the movement of an object/s across visual space. 
Given the high of prevalence of ME/CFS across the population and common reports of visual 
problems associated with the condition, it is apparent that developing visual assessment tasks 
sensitive to ME/CFS may provide a valuable method of understanding and diagnosing the 
illness. 
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 Table 1. Mean (and standard deviation) age, gender and level of education of participants alongside myalgic encephalomyelitis/chronic fatigue 
syndrome (ME/CFS) categorisation for patients. 
  
  
 ME/CFS Definition 
 Age Age 
Range 
Education
a 
Gender 
(females/n) 
 CFS 
(Fukuda et al., 1994).  
Canadian 
(Carruthers et al., 2003) 
International 
(Carruthers et al., 2011) 
 
Patients 44.22 (13.25) 24-71 2.85 (0.59) 14/20 20/20 15/20 11/20 
Controls 44.63 (13.41) 24-72 3.20 (0.89) 14/20 N/A N/A N/A 
Sig 
difference 
t < 1  t = 1.46, ns     
a
Four levels of education: 1 = some high school (GCSE or equivalent); 2 = partial college (A level or equivalent); 3 = college/university degree; 4 = graduate professional 
degree (masters/doctorate) 
 Figure Captions 
Figure 1. Prosaccade and antisaccade performance for patients and controls. a: Mean error 
rate (proportion). b: Saccade latency (msecs). c: Positional error (distance between the eye 
position and the desired fixation point). Error bars represent ± 1 SE. 
Figure 2. Smooth pursuit performance for patients and controls across three test runs. a: Mean 
maintenance gain. b: Global root mean square error. c: Catch up saccade frequency (Hz). d: 
Anticipatory saccade frequency (Hz). Error bars are ± 1 SE. 
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